Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
REDUCE-IT: CV Outcomes With Icosapent Ethyl by Baseline LDL-C
Author(s): Deepak L Bhatt Added: 1 month ago
In this insightful interview, Dr Deepak Bhatt (Mount Sinai Hospital, US) joins us to discuss findings from a post-hoc analysis of the REDUCE-IT trial, examining how icosapent ethyl affects cardiovascular outcomes across different baseline LDL-C levels.The study included 8,175 statin-treated patients with elevated cardiovascular risk and triglyceride levels between 135-499mg/dL. All participants… View more

Prevention & Chronic Conditions
Author(s): Billy A Caceres Added: 1 year ago
Dr Billy A Caceres (Columbia University School of Nursing, US), a renowned expert and lead author, recently discussed findings from the study titled "Differences in Ideal Cardiovascular Health Between Sexual Minority and Heterosexual Adults" published in JAMA Cardiology. The study aimed to determine whether there are disparities in cumulative cardiovascular health (CVH) scores between sexual… View more

Demographic
Cardiovascular Involvement in Fabry’s Disease
Author(s): Emanuele Monda , Luigi Falco , Giuseppe Palmiero , et al Added: 1 year ago

Heart Failure
CardioNerds @AHA23: Presidential Advisory on CKM Health
Author(s): Ramy Doss , Chiadi Ndumele Added: 1 year ago
AHA 2023 — CardioNerds Ambassador, Dr Ramy Doss (Nazareth Hospital, US) is joined by Dr Chiadi E Ndumele (Johns Hopkins University, US) to talk about AHA's Presidential Advisory on Cardiovascular-Kidney-Metabolic Health (CKM).The presidential advisory focuses on the cardiovascular-kidney-metabolic (CKM) syndrome, a systemic disorder connecting heart disease, kidney disease, diabetes and obesity… View more

Guidelines & Statements

Prevention & Chronic Conditions
ESC 23: Economic Burden of CVD in the EU
Author(s): Ramón Luengo-Fernández Added: 1 year ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU. This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282… View more

Guidelines & Statements
Cardiovascular Research Technologies 2024
Start date: Mar 09, 2024 End date: Mar 12, 2024
Cardiovascular Research Technologies (CRT) is a premier educational platform delving into the forefront of cardiovascular technology and procedures, tailored for the discerning audience of physicians and healthcare professionals. This forum curates an exceptional educational experience, catering to interventional cardiologists, general cardiologists, cardiothoracic and vascular surgeons,… View more

Heart Failure
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at American College of Cardiology Congress
Added: 1 year ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryTwo late-breaking clinical trials addressing cardiovascular outcomes in patients with diabetes were presented this week at the American College of Cardiology meeting in Atlanta, USA. One of these trials looked at the effects of the hyperactivation of the polyol pathway on diabetic cardiomyopathy (DbCM) and the other the effects of chelation therapy in patients with diabetes… View more

Heart Failure

Cardiovascular Renal Metabolic
Cardiovascular Manifestations in Post-COVID-19 Patients
Author(s): Angela Cozma , Violeta Briciu , Adela Viviana Sitar-Tăut , et al Added: 3 weeks ago

Heart Failure

Prevention & Chronic Conditions
ISCP
The International Society of Cardiovascular Pharmacotherapy was created to support and promote ethical, evidence-based, cardiovascular pharmacotherapy worldwide. ISCP represents an ideal forum for open discussions on all issues related to cardiovascular pharmacotherapy and the society endeavours to foster collaboration among health professionals around the World. ISCP promotes education, research… View more
TCT Connect
TCT Transcatheter Cardiovascular Therapeutics (TCT) is organised by Radcliffe Cardiology partner CardioVascular Research Foundation (CFR).TCT provides physicians opportunities for hands-on training, interactive learning, live case demonstrations, and to network, all with access to world-class KOLs and experts! View more